Device Trial Radar · NCT00833612
Counterpulsation Reduces Infarct Size Pre-PCI for AMI
Last checked: Nov 19, 2026Latest source record: Jun 27, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
339
Actual
Start
Dec 2008
Primary completion
Mar 2011
Study completion Mar 2011
Sponsor
- Lead sponsor
- Datascope Corp.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Duke University; Flinders Medical Centre
- First posted
- Feb 2, 2009
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Subjects with anterior acute STEMI who receive an IABC before primary PCI will have decreased MI size.
Conditions
- Acute Myocardial Infarction (AMI)
Interventions
Counterpulsation with IABDevice
IABC pre-reperfusion PCI
Primary outcomes
What the sponsor says the trial is designed to measure.
- To determine whether IABC before mechanical reperfusion decreases myocardial infarct (MI) size.Time frame: 3-5 days
Locations
40 sites in 10 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
University of Southern California
Los Angeles, California
Washington Hospital Center
Washington D.C., District of Columbia
37 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.